Non-Malaysian citizens are subject to 6% SST, to be verified and paid at the counter before screening.
Thalassemia Screening, also known as “thalassemia carrier test”, is a blood and genetic test to determine whether an individual carries the thalassemia gene mutation.
Thalassemia is an inherited blood disorder common in Southeast Asia and the Mediterranean. Carriers usually have no symptoms, but if both partners are carriers, their child may be born with severe thalassemia, requiring lifelong blood transfusions or even bone marrow transplantation.
Screening usually includes:
A simple blood draw is required. Report turnaround may range from several days to 1–2 weeks depending on the tests.
Q1: Do carriers of thalassemia have symptoms?
A: Most carriers show no obvious symptoms and can only be confirmed through blood and genetic testing.
Q2: What if both partners are carriers?
A: Genetic counseling is recommended. Prenatal screening and medical interventions may reduce the risk of severe cases in children.
Q3: Can thalassemia be cured?
A: Severe thalassemia often requires regular blood transfusions and iron chelation therapy. Some patients may be cured with bone marrow transplantation.